Unique considerations in the evaluation of antibacterials in clinical trials for pediatric community-acquired pneumonia
John S Bradley1, George H McCracken
1Division of Pediatric Infectious Diseases, Rady Children's Hospital San Diego, San Diego, California 92123, USA. jbradley@rchsd.org
Insights
Few placebo-controlled trials exist for pediatric community-acquired pneumonia (CAP) antibiotic therapy. Due to ethical concerns and diagnostic challenges, alternative trial designs and patient-reported outcomes are crucial for evaluating pediatric CAP treatments.
Area of Science:
- Pediatric infectious diseases
- Clinical trial methodology
- Pharmacology
Background:
- Antibiotic therapy is standard for community-acquired pneumonia (CAP) due to early dramatic mortality reductions.
- Pediatric placebo-controlled trials for CAP ceased after 1940 due to ethical considerations for vulnerable populations.
- Current pediatric CAP trials often use comparative noninferiority designs for antibiotic approval.
Purpose of the Study:
- To review the history and challenges of clinical trials for pediatric community-acquired pneumonia (CAP).
- To discuss the limitations in distinguishing causative pathogens in pediatric CAP.
- To explore alternative outcome measures for pediatric CAP clinical trials.
Main Methods:
- Review of historical clinical trial data and methodologies for pediatric CAP.
- Analysis of ethical considerations in pediatric clinical research.
- Discussion of diagnostic challenges and outcome measure limitations in pediatric CAP studies.
Main Results:
- Limited availability of placebo-controlled, randomized, prospective trials for pediatric CAP antibiotic therapy.
- Difficulty in differentiating bacterial, viral, or atypical pathogens in pediatric CAP.
- Patient- or parent-reported outcomes are proposed as suitable endpoints for pediatric CAP trials.
Conclusions:
- Ethical constraints and diagnostic uncertainties necessitate alternative approaches for pediatric CAP clinical trials.
- Noninferiority trials and patient-reported outcomes are viable strategies for evaluating pediatric CAP treatments.
- Future research should focus on acceptable and informative trial designs for pediatric antibiotic efficacy studies.
Abstract:
There are few placebo-controlled, randomized, prospective clinical trials of antibiotic therapy for community-acquired pneumonia (CAP) in children. The reduction in mortality seen in early trials of antibacterials for treatment of bacterial CAP in adults and children was dramatic and led to the adoption of antibacterial therapy as the standard of care for CAP in both adults and children. Because of the efficacy of antibacterials for treatment of CAP in adults and the reluctance of society to place children at risk of adverse outcomes in placebo-controlled clinical trials, pediatric investigations of this type were not performed after 1940. Instead, comparative trials were subsequently conducted and reported. More recently, comparative trials using a noninferiority trial design have been used by regulatory agencies to grant approval of antibiotic therapy for pediatric CAP. We cannot reliably distinguish between pneumonia cases caused by bacterial, viral, or atypical pathogens among the relatively homogeneous population of children with CAP who are enrolled into clinical trials. Patient- or parent-reported outcomes represent an option for appropriate, defined clinical trial outcomes for pediatric CAP, because the disease in children has a relatively short and potentially self-resolving clinical course. Clinical trials that require invasive techniques for diagnosis and placebo-controlled randomized trials are not acceptable for children, who are considered to be a vulnerable population.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
01:14Atypical Pneumonia
01:30Pneumonia III: Complications and Assessment